Citations

Clear

4847 citation(s) found for "Tu, Eric".

O2‐03‐01: TOMM40, APOE and preclinical memory decline
Caselli, Richard J. , Huentelman, Matthew J. , Saunders, Ann M. , Reiman, Eric M. , Roses, Allen D., Dueck, Amylou C. , Lutz, Michael W. , Locke, Dona E.C.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2011.05.850 Get It

O4‐05‐04: Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population‐based study
Roberts, Rosebud O., Pankratz, Shane, Tangalos, Eric G., Rocca, Walter A. , Petersen, Ronald C. , Geda, Yonas E. , Knopman, David S. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2011.05.2000 Get It

P4‐102: Age related changes in the default mode network are more advanced in Alzheimer's disease
Gunter, Jeffrey L. , Przybelski, Scott A. , Avula, Ramesh, Petersen, Ronald C. , Jones, David T. , Machulda, Mary M. , Vemuri, Prashanthi , McDade, Eric , Zeng, Guang‐Zhi , Senjem, Matthew L. , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2011.05.2123 Get It

P4‐089: Prevalence of vasogenic edema and microhemorrhage in an Alzheimer's disease study population at baseline
Carlson, Christopher, Estergard, Wahiba, Oh, Joonmi, Suhy, Joyce, Barakos, Jerome , Siemers, Eric , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2011.05.2110 Get It

IC‐P‐086: Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease
Burns, Christine , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Dan, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2011.05.152 Get It

O3‐03‐02: Composite cognitive endpoints with improved power to detect presymptomatic Alzheimer's disease treatment effects in APOE4 carriers: Findings from the Alzheimer's prevention initiative
Hendrix, Suzanne , Ayutyanont, Napatkamon , Tariot, Pierre N. , Fleisher, Adam , Caselli, Richard J. , Langlois, Carolyn, Reiman, Eric M. , Langbaum, Jessica B. S. , Chen, Kewei , Bennett, David A.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2011.05.2401 Get It

IC‐P‐165: Age‐related changes in the default mode network are more advanced in Alzheimer's disease
Jones, David, Gunter, Jeffrey L. , Przybelski, Scott A. , Avula, Ramesh, Petersen, Ronald, Jones, David, Machulda, Mary M. , Vemuri, Prashanthi , McDade, Eric , Zeng, Guang‐Zhi , Senjem, Matthew L. , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2011.05.179 Get It

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
Carlson, Christopher, Estergard, Wahiba, Oh, Joonmi, Suhy, Joyce, Jack, Clifford R. , Siemers, Eric , Barakos, Jerome , Jack, Clifford R

Mayo Clinic

Alzheimer's & Dementia | July 25, 2011 | Volume: 7 | Issue: 4 | Pages: 396-401

10.1016/j.jalz.2011.05.2353 | PMID 21784350 Get It

BackgroundCerebral vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy. VE may be associated with central nervous system pathology with blood–brain barrier disruptions; however, less is known about the prevalence of naturally occurring VE in patients with Alzheimer's disease (AD).MethodsFluid‐attenuated inversion recovery imaging sequences were obtained from four ongoing multicenter, randomized, double‐blind, placebo‐controlled, phase 3 trials in patients with mild‐to‐moderate AD. The first set of baseline scans was from patients in volumetric magnetic resonance imaging addenda in the Interrupting Alzheimer's Dementia by EvaluatiNg Treatment of Amyloid PaThologY (IDENTITY) studies examining semagacestat, a γ‐secretase inhibitor (cohort 1, n = 621). The second set of baseline scans was from the EXPanding Alzheimer's Disease InvestigaTIONs (EXPEDITION) studies examining solanezumab, an anti‐Aβ monoclonal antibody (cohort 2, n = 2141). Readers were blinded to patient‐identifying information and future treatment. A third set of baseline scans was from the first 700 patients who underwent protocol‐specified magnetic resonance imaging before randomization in the EXPEDITION studies (cohort 3). The analysis used three neuroradiologists: two performed independent primary interpretations and the third was the adjudicator. Readers were blinded to patient information, treatment, protocol, and time point.ResultsFour cases of asymptomatic VE were detected at baseline/screening. Two VE cases were due to underlying extra‐axial mass lesions. The third VE case was associated with numerous microhemorrhages in keeping with cerebral amyloid angiopathy‐related inflammation or Aβ‐related angiitis. The final VE case demonstrated localized sulcal fluid‐attenuated inversion recovery imaging hyperintensity. No VE was detected in cohort 3 by readers blinded to patient baseline status.ConclusionsVE seems to be rare at baseline in patients with AD in clinical trials, 2 of 2762 associated with AD. Additional cohorts should be evaluated to support these findings.
Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model
Chen, Christopher Y. , May, Shannon M., Barry, Mary E., Barry, Mary E., Barry, Michael A., Barry, Michael A., Barry, Michael A. , Weaver, Eric A. , Barry, Mary E., Barry, Michael A., Barry, Michael A., Weaver, Eric A , Barry, Michael A

Mayo Clinic

Human Gene Therapy | July 19, 2011 | Volume: 22 | Issue: 9 | Pages: 1095-1100

10.1089/hum.2011.071 | PMID 21770794 Get It